OR WAIT null SECS
Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.
Marlborough, MA-Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO. The device combines spectral optical coherence tomographic (OCT) imaging with a scanning laser ophthalmoscope (SLO).
Microperimetry assesses retinal sensitivity and provides a precise correlation between structural pathology and corresponding visual functional defects. The OptosOCT SLO is the only device on the market that can conduct structural OCT and functional microperimetry testing, according to the company.
“We continue to strive to provide innovative technology to the market,” said Roy Davis, chief executive officer of Optos. “With this 510(k) clearance for microperimetry, we once again offer a unique tool that allows eye-care professionals to see more, diagnose more, and treat more diseases earlier.”
For more articles in this issue of Ophthalmology Times eReport, click here.